REFERENCES
- Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. Lippincott Williams & Wilkins: Philadelphia, 2003.
- Harris GJ, Jakobiec FA. Cavernous hemangioma of the orbit. J Neurosurg 1979;51:219–228.
- Henderson JW, Farrow GM, Garrity JA. Clinical course of an incompletely removed cavernous haemangioma of the orbit. Ophthalmology 1990;97:625–628.
- Limawararut V, Davis G, Crompton J, et al. Recurrent multiple cavernous hemangiomas of the orbit in association with systemic tumours. Am J Ophthalmol 2006;141:943–945.
- Zauberman H, Feinsod M. Orbital hemangioma growth during pregnancy. Acta Ophthal 1970;48:929–933.
- Di Tommaso L, Scarpellini F, Salvi F, et al. Progesterone receptor expression in orbital cavernous hemangiomas. Virchows Arch 2000;436:284–288.
- Hood I. Cavernous hemangioma of the orbit. Arch Ophthalmol 1970;83:49–53.
- Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285–294.
- Mejia C, Navarro S, Pellín A, et al. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors. OncolRepts 2003;10:243–247.
- Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311–322.
- Wu J, Richer J, Horwitz KB, Hyder SM. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. Cancer Res 2004;64:2238–2244.
- Notelet L, Houtteville JP, Khoury S, et al. Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: an immunocytochemical study of 42 cases. Surg Neurol 1997;47:364–370.
- Nagasaka M, Naganuma H, Satoh E. Growth Potential of orbital cavernous hemangioma suggested by Vascular Endothelial Growth Factor and its Receptor FLK-1. Neurol Med Chir 2007;47:5–10.
- Maiuri F, Cappabianca P, Gangemi M, et al. Clinical progression and familial occurrence of cerebral cavernous angiomas: The role of angiogenic and growth factors. Neurosurg Focus 2006;21:E3.
- Uranishi R, et al. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery 2002;50(1):110–115.
- Breugem CB, van der Horst CMAM, Hennekam RCM. Progress towards understainding vascular malformations. Plast Reconstruct Surg 2001.107(6):1509–1523.
- Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s and a subset of angiosarcomas. Mod Pathol, 2002;15:434–440.